The Europe Healthcare Bioconvergence Market would witness market growth of 6.4% CAGR during the forecast period (2022-2028).
The utilization of digital tools like AI-powered applications, mobile health treatment, and digital diagnostic platforms can be leveraged to promote efficiency and improve access to high-quality healthcare. We can assist individuals in receiving better healthcare more quickly by comprehending and imitating natural mechanisms.
By enhancing the human-computer interface, we may enhance digital health platforms and applications. In other words, we can create better UX (user experience) and HX (human experience) by studying how various elements in nature interact with one another. The global healthcare sector is entering a new age for mRNA as it seeks to continually strengthen our immune systems, or "forever boosting," to protect from potential viral infections.
mRNA's potential for treating non-communicable disorders like cancer is also being studied more and more. The healthcare sector needs more robust analytical tools as a result of the trend toward the wider application of mRNA treatments and, more broadly, in the study and development of precision and personalized therapies such as genomic medicines. Knowing what a compound is and what makes it up is no longer sufficient.
The UK has the potential to set a global standard for health technology. The region already has a number of the top health tech businesses in the world, delivering new ideas and enhancing the stature of our outstanding scientific and research foundation abroad. Also, the region has the largest healthcare system in the world in the NHS. The country has the chance to develop an ecosystem that consistently produces the best health tech, including novel techniques and insights that can improve health outcomes throughout the world.
The Germany market dominated the Europe Healthcare Bioconvergence Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $12,786.2 million by 2028. The UK market is anticipated to grow at a CAGR of 5.5% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022 - 2028).
Based on Application, the market is segmented into Drug Discovery, Precision Medicine, Regenerative Medicine, Diagnostic & Biological Sensors, Bioelectronics, Nanorobotics for Drug Delivery, Engineered Living Materials, and Optogenetics. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Healthcare Bioconvergence Market will Hit $169.9 Billion by 2028, at a CAGR of 7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BiomX, Inc., Singota Solutions, Anima Biotech Inc., Ginkgo Bioworks Holdings, Inc., SetPoint Medical Corporation, Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences), and BICO Group AB (publ).
Scope of the Study
Market Segments Covered in the Report:
By Application
- Drug Discovery
- Precision Medicine
- Regenerative Medicine
- Diagnostic & Biological Sensors
- Bioelectronics
- Nanorobotics for Drug Delivery
- Engineered Living Materials
- Optogenetics
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- BiomX, Inc.
- Singota Solutions
- Anima Biotech Inc.
- Ginkgo Bioworks Holdings, Inc.
- SetPoint Medical Corporation
- Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
- BICO Group AB (publ)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Healthcare Bioconvergence Market, by Application
1.4.2 Europe Healthcare Bioconvergence Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Healthcare Bioconvergence Market by Application
3.1 Europe Drug Discovery Market by Country
3.2 Europe Precision Medicine Market by Country
3.3 Europe Regenerative Medicine Market by Country
3.4 Europe Diagnostic & Biological Sensors Market by Country
3.5 Europe Bioelectronics Market by Country
3.6 Europe Nanorobotics for Drug Delivery Market by Country
3.7 Europe Engineered Living Materials Market by Country
3.8 Europe Optogenetics Market by Country
Chapter 4. Europe Healthcare Bioconvergence Market by Country
4.1 Germany Healthcare Bioconvergence Market
4.1.1 Germany Healthcare Bioconvergence Market by Application
4.2 UK Healthcare Bioconvergence Market
4.2.1 UK Healthcare Bioconvergence Market by Application
4.3 France Healthcare Bioconvergence Market
4.3.1 France Healthcare Bioconvergence Market by Application
4.4 Russia Healthcare Bioconvergence Market
4.4.1 Russia Healthcare Bioconvergence Market by Application
4.5 Spain Healthcare Bioconvergence Market
4.5.1 Spain Healthcare Bioconvergence Market by Application
4.6 Italy Healthcare Bioconvergence Market
4.6.1 Italy Healthcare Bioconvergence Market by Application
4.7 Rest of Europe Healthcare Bioconvergence Market
4.7.1 Rest of Europe Healthcare Bioconvergence Market by Application
Chapter 5. Company Profiles
5.1 BiomX, Inc.
5.1.1 Company Overview
5.1.2 Research & Development Expenses
5.2 Galvani Bioelectronics, Ltd. (GlaxoSmithKline plc and Verily Life Sciences)
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Segmental and Regional Analysis
5.2.4 Research & Development Expenses
5.3 BICO Group AB (publ)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Segmental and Regional Analysis
5.3.4 Recent strategies and developments:
5.3.4.1 Partnerships, Collaborations, and Agreements:
5.3.4.2 Acquisition and Mergers:
5.4 Ginkgo Bioworks Holdings, Inc.
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Research & Development Expenses
5.4.4 Recent strategies and developments:
5.4.4.1 Partnerships, Collaborations, and Agreements:
5.5 Singota Solutions
5.5.1 Company Overview
5.6 Anima Biotech Inc.
5.6.1 Company Overview
5.7 Setpoint Medical Corporation
5.7.1 Company Overview
TABLE 1 Europe Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 2 Europe Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 3 Europe Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 4 Europe Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 5 Europe Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Precision Medicine Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Precision Medicine Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Regenerative Medicine Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Regenerative Medicine Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Diagnostic & Biological Sensors Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Diagnostic & Biological Sensors Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Bioelectronics Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Bioelectronics Market by Country, 2022 - 2028, USD Million
TABLE 15 Europe Nanorobotics for Drug Delivery Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Nanorobotics for Drug Delivery Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Engineered Living Materials Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Engineered Living Materials Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Optogenetics Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Optogenetics Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Healthcare Bioconvergence Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Healthcare Bioconvergence Market by Country, 2022 - 2028, USD Million
TABLE 23 Germany Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 24 Germany Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 25 Germany Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 26 Germany Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 27 UK Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 28 UK Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 29 UK Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 30 UK Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 31 France Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 32 France Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 33 France Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 34 France Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 35 Russia Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 36 Russia Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 37 Russia Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 38 Russia Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 39 Spain Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 40 Spain Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 41 Spain Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 42 Spain Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 43 Italy Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 44 Italy Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 45 Italy Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 46 Italy Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 47 Rest of Europe Healthcare Bioconvergence Market, 2018 - 2021, USD Million
TABLE 48 Rest of Europe Healthcare Bioconvergence Market, 2022 - 2028, USD Million
TABLE 49 Rest of Europe Healthcare Bioconvergence Market by Application, 2018 - 2021, USD Million
TABLE 50 Rest of Europe Healthcare Bioconvergence Market by Application, 2022 - 2028, USD Million
TABLE 51 Key Information – BiomX, Inc.
TABLE 52 Key Information – Galvani Bioelectronics, Ltd.
TABLE 53 Key Information – BICO Group AB (publ)
TABLE 54 Key Information – Ginkgo Bioworks Holdings, Inc.
TABLE 55 Key Information – Singota Solutions
TABLE 56 Key Information – Anima Biotech Inc.
TABLE 57 Key Information – Setpoint Medical Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: BICO Group AB (publ)